drugset / Trial / NCT02795273

Efficacy and Safety of Grass-SPIRE Registration Study

NCT02795273 ↗

Phase 2/3 Withdrawn Circassia Limited
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the safety of Grass-SPIRE compared with placebo and to evaluate the treatment effect of Grass-SPIRE on symptoms and use of rescue medication during the grass pollen season

Timeline

Start
2016-05
Primary completion
2018-10
Completion
—

Outcome

Outcome not reported

Stopped: “Decision made to stop study following availability of results from another study”

Drugs

EvaluationDrugModalityDoseRoute
Subject Grass-SPIRE Unknown — Other

Indications